(Medical Xpress)—Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce ...
Jun 5, 2013
0
0
(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have found that a new formulation of a promising anticancer agent, the small chemical molecule FL118, is even more effective in controlling two types ...
Apr 3, 2013
0
0
University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.
Mar 27, 2013
0
0
Following several years of study, investigators have found more evidence that viral therapy to treat solid tumors can be enhanced by blocking the body's natural immune response.
Mar 13, 2013
0
0
(Medical Xpress)—The latest research into the intricate processes that let substances into and out of cells will help to lay the foundations for the next generation of therapies for major diseases.
Mar 12, 2013
0
0
(Medical Xpress)—Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more ...
Feb 27, 2013
0
0
(HealthDay)—Lactate dehydrogenase (LDH) levels may be predictive of success in treating chemotherapy-naive patients with advanced melanoma with a combination of elesclomol plus paclitaxel, according to research published ...
Feb 22, 2013
0
0
In laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors.
Feb 14, 2013
0
0
In a first-ever comprehensive study of 124 natural product combinations, a team of researchers from the National University of Singapore (NUS) and Tsinghua University, led by Professor Chen Yu Zong from the Department of ...
Feb 7, 2013
0
0
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with ...
Feb 7, 2013
0
0
